Chevalier E, Viana M, Artaud A, Haddouchi S, Chulia D
Faculté de Pharmacie, Laboratoire de Pharmacie Galénique, Université de Limoges, CNRS SPCTS UMR 6638, Limoges Cedex, France.
Talanta. 2009 Feb 15;77(4):1545-8. doi: 10.1016/j.talanta.2008.09.046. Epub 2008 Oct 5.
This paper describes the use of a novel flow cell, the T-cell, adapted to the flow-through cell apparatus, for the study of ibuprofen release from implantable loaded pellets and its performance in comparison to the compendial tablet cell. In fact, the drug targeting with a local delivery system becomes increasingly used to achieve therapeutic doses directly on the implantation site while maintaining a low systemic drug level. Due to the long and expensive in vivo studies necessary to evaluate the efficacy of such delivery systems, in vitro dissolution techniques are performed despite there being no standard method in the biomaterial field. In this work, dissolution profiles obtained with the T-cell configuration clearly indicate a prolonged release of ibuprofen. Dissolution data fitted to Higuchi, Hixson-Crowell, Ritger-Peppas and Kopcha equations indicate the coexistence of diffusion and erosion mechanisms governing ibuprofen release. T-cell adapted to the standard flow-through dissolution apparatus is shown to better simulate in vivo conditions than the tablet cell. This is relevant for in vivo/in vitro correlations.
本文描述了一种新型流通池——T 细胞流通池,它适用于流通池装置,用于研究布洛芬从可植入载药微丸中的释放情况,并与药典规定的片剂溶出池比较其性能。事实上,利用局部给药系统进行药物靶向递送越来越多地用于在维持较低全身药物水平的同时,直接在植入部位达到治疗剂量。由于评估此类给药系统的疗效需要进行漫长且昂贵的体内研究,尽管生物材料领域尚无标准方法,但仍开展了体外溶出技术研究。在这项工作中,采用 T 细胞配置获得的溶出曲线清楚地表明布洛芬的释放得到了延长。将溶出数据拟合至 Higuchi、Hixson-Crowell、Ritger-Peppas 和 Kopcha 方程表明,控制布洛芬释放的是扩散和侵蚀机制的共同作用。结果表明,适用于标准流通式溶出装置的 T 细胞流通池比片剂溶出池能更好地模拟体内情况。这对于体内/体外相关性研究具有重要意义。